UBS’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

UBS’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Hold	0	–	–	–	10379
2014 Q2	–	Sell	-1	Closed	-$8K	–	10442
2014 Q1	$8K	Buy	+1	New	+$17.1K	﹤0.01%	9122

Other funds holding CANF

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

UBS's CANF Position: Q3 2014 in Review

UBS held its Can-Fite BioPharma American Depositary Shares (CANF) position steady in Q3 2014 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #10379.

UBS first reported a position in CANF in Q1 2014 and has held it in 1 quarter since. The position peaked at $8K in Q1 2014. 2 funds tracked by Wall St. Rank hold CANF as of Q3 2014.

UBS held 0 shares of Can-Fite BioPharma American Depositary Shares worth $0 as of Q3 2014.
UBS left its Can-Fite BioPharma American Depositary Shares share count unchanged in Q3 2014.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10379 holding.
UBS first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2014 and has held it in 1 quarter since.
UBS's Can-Fite BioPharma American Depositary Shares position peaked at $8K in Q1 2014.
2 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.